Sponsored By

Listen in to see what regulations are affecting the dietary supplement industry.

Jon Benninger

October 14, 2021

Join us for the third edition of this new series of updates from the nation’s capital with CRN—your team in Washington, D.C., connected to Congress, regulators and other key influencers affecting the dietary supplement industry.

In our newest installment, CRN President & CEO Steve Mister and CRN Vice President, Government Relations, Julia Gustafson, will discuss:

  • Why the industry should be circumspect about allowing FDA to set a maximum safe level for CBD—and the precedent this could set for other supplement ingredients

  • The dietary supplement industry’s drug preclusion predicament—affecting CBD and now NAC, this problem is not going away and the industry needs to push back

  • Legislation that would allow consumers to purchase supplements with HSA/FSA funds—what are the real prospects for passage?

About the Author(s)

Jon Benninger


Jon Benninger is vice president and market leader at Informa Markets. He focuses on the strategic direction and growth of the SupplySide portfolio, which includes SupplySide West, SupplySide East, Natural Products Insider and Food & Beverage Insider. He coordinates with leaders of the other Informa health and nutrition events and brands, including Natural Products Expo, Vitafoods, Food ingredients, NEXT and Nutrition Business Journal. Benninger joined the company in 1995 as the founding editor of the company’s first trade magazine for the nutrition industry.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like